New to Moneycontrol - Sign up now
Its easy and FREE!
OR connect with
connect with
Don’t have an account?
Create One
9th-Jul-2012 10:41Source: BSE
Aurobindo Pharm - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Kambam Spoorthi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
More Announcements on:
24th-May-2013 14:46Source: BSE
20th-May-2013 11:10Source: BSE
17th-May-2013 12:22Source: BSE
Aurobindo Pharm - FY13 results on May 30, 2013
6th-May-2013 09:36Source: NSE
Aurobindo Pharma Limited Press Release
4th-May-2013 15:26Source: BSE
Aurobindo Pharm - Aurobindo Pharma receives USFDA Approvals for Tamsulosin HCL Capsules and Clindamycin Palmitate Hydrochloride for Oral Solution (Pediatric)
30th-Apr-2013 13:39Source: NSE
Aurobindo Pharma Limited
30th-Apr-2013 13:21Source: BSE
Aurobindo Pharm - Aurobindo Pharma receives USFDA Approval for Quinapril Tablets
26th-Apr-2013 14:49Source: BSE
Aurobindo Pharm - Aurobindo Pharma receives USFDA Approval for Cefadroxil Oral Suspension
26th-Apr-2013 13:31Source: NSE
3rd-Apr-2013 12:27Source: BSE
Aurobindo Pharm - Aurobindo Pharma receives tentative approval for Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Meeting Date
Remark
2013-05-30
Audited Results & Final Dividend
Login to moneycontrol.com
Existing Members, Login
Keep me signed in
Forgot Password?
Live: Mumbai Police arrests Meiyappan, CSK faces threat of termination
NSE: AUROPHARMA
Source: 
